News Home

Will Puma Biotechnology Inc (PBYI) Stay at the Top of the Healthcare Sector?

Thursday, March 24, 2022 03:43 PM | InvestorsObserver Analysts

Mentioned in this article

Will Puma Biotechnology Inc (PBYI) Stay at the Top of the Healthcare Sector?

A rating of 73 puts Puma Biotechnology Inc (PBYI) near the top of the Healthcare sector according to InvestorsObserver. Puma Biotechnology Inc's score of 73 means that it ranks higher than 73% of stocks in the sector. In addition, its overall score of 23 ranks it higher than 23% of all stocks.

Overall Score - 23
PBYI has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on PBYI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 23 would rank higher than 23 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Puma Biotechnology Inc Stock Today?

Puma Biotechnology Inc (PBYI) stock is down -4.97% while the S&P 500 has risen 1.19% as of 3:42 PM on Thursday, Mar 24. PBYI has fallen -$0.15 from the previous closing price of $3.02 on volume of 255,015 shares. Over the past year the S&P 500 is up 15.95% while PBYI has fallen -69.98%. PBYI lost -$0.72 per share the over the last 12 months. Click Here to get the full Stock Report for Puma Biotechnology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App